These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32482649)

  • 1. Association Between Centromere- and Topoisomerase-specific Immune Responses and the Degree of Microangiopathy in Systemic Sclerosis.
    van Leeuwen NM; Wortel CM; Fehres CM; Bakker JA; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK
    J Rheumatol; 2021 Mar; 48(3):402-409. PubMed ID: 32482649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-topoisomerase, but not anti-centromere B cell responses in systemic sclerosis display active, Ig-secreting cells associated with lung fibrosis.
    Wortel CM; Liem SI; van Leeuwen NM; Boonstra M; Fehres CM; Stöger L; Huizinga TW; Toes RE; De Vries-Bouwstra J; Scherer HU
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37507206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nailfold videocapillaroscopic patterns and serum autoantibodies in systemic sclerosis.
    Cutolo M; Pizzorni C; Tuccio M; Burroni A; Craviotto C; Basso M; Seriolo B; Sulli A
    Rheumatology (Oxford); 2004 Jun; 43(6):719-26. PubMed ID: 15026581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could the IgA isotype provide additional information in systemic sclerosis patients? A retrospective study entailing IgA isotyping in a Mediterranean systemic sclerosis cohort.
    Pérez-Isidro A; Lledó-Ibáñez GM; de Moner N; Torradeflot M; Martínez MJ; Espinosa G; Tena Campos M; Grundhuber M; Viñas O; Ruiz-Ortiz E
    Clin Exp Rheumatol; 2023 Sep; ():. PubMed ID: 37812465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting cardiopulmonary involvement in patients with systemic sclerosis: complementary value of nailfold videocapillaroscopy patterns and disease-specific autoantibodies.
    Markusse IM; Meijs J; de Boer B; Bakker JA; Schippers HPC; Schouffoer AA; Ajmone Marsan N; Kroft LJM; Ninaber MK; Huizinga TWJ; de Vries-Bouwstra JK
    Rheumatology (Oxford); 2017 Jul; 56(7):1081-1088. PubMed ID: 27940596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nailfold videocapillaroscopy in systemic sclerosis: diagnostic and follow-up parameters and correlation with both specific serum autoantibodies and subsets of skin involvement].
    Sulli A; Burroni A; Tuccio M; Pizzorni C; Craviotto C; Ghio M; Basso M; Seriolo B; Cutolo M
    Reumatismo; 2004; 56(1):36-45. PubMed ID: 15105908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.
    van Leeuwen NM; Boonstra M; Bakker JA; Grummels A; Jordan S; Liem S; Distler O; Hoffmann-Vold AM; Melsens K; Smith V; Truchetet ME; Scherer HU; Toes R; Huizinga TWJ; de Vries-Bouwstra JK
    Arthritis Rheumatol; 2021 Dec; 73(12):2338-2347. PubMed ID: 34042326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of nailfold microvascular damage and antinuclear antibody pattern in systemic sclerosis.
    Sulli A; Ruaro B; Smith V; Pizzorni C; Zampogna G; Gallo M; Cutolo M
    J Rheumatol; 2013 May; 40(5):634-9. PubMed ID: 23457379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis.
    Dick T; Mierau R; Bartz-Bazzanella P; Alavi M; Stoyanova-Scholz M; Kindler J; Genth E
    Ann Rheum Dis; 2002 Feb; 61(2):121-7. PubMed ID: 11796397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and systemic sclerosis: influence on microangiopathy and expression of anti-topoisomerase I antibodies in a monocentric cohort.
    Ciaffi J; van Leeuwen NM; Huizinga TWJ; de Vries-Bouwstra JK
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):25-28. PubMed ID: 32242801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-carbamylated protein antibodies in systemic sclerosis.
    Liem SIE; Hoekstra EM; Levarht EWN; Dorjee AL; Scherer HU; Toes REM; Huizinga TWJ; de Vries-Bouwstra JK; Fehres CM
    Arthritis Res Ther; 2023 Jul; 25(1):123. PubMed ID: 37480150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-annexin V autoantibodies and vascular abnormalities in systemic sclerosis: a longitudinal study.
    Horimoto AMC; de Jesus LG; de Souza AS; Rodrigues SH; Kayser C
    Adv Rheumatol; 2020 Jul; 60(1):38. PubMed ID: 32736594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update.
    Hysa E; Campitiello R; Sammorì S; Gotelli E; Cere A; Pesce G; Pizzorni C; Paolino S; Sulli A; Smith V; Cutolo M
    Antibodies (Basel); 2023 Jan; 12(1):. PubMed ID: 36648887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study.
    Sulli A; Paolino S; Pizzorni C; Ferrari G; Pacini G; Pesce G; Carmisciano L; Smith V; Cutolo M
    Rheumatology (Oxford); 2020 May; 59(5):1051-1058. PubMed ID: 31750929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of coexisting antitopoisomerase I and anticentromere antibodies in patients with systemic sclerosis: a EUSTAR group-based study.
    Heijnen IA; Foocharoen C; Bannert B; Carreira PE; Caporali R; Smith V; Kumánovics G; Becker MO; Vanthuyne M; Simsek I; Bocelli-Tyndall C; Walker UA
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):96-102. PubMed ID: 23101460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts.
    Liem SIE; Boonstra M; le Cessie S; Riccardi A; Airo P; Distler O; Matucci-Cerinic M; Caimmi C; Siegert E; Allanore Y; Huizinga TWJ; Toes REM; Scherer HU; de Vries-Bouwstra JK;
    Lancet Rheumatol; 2022 Oct; 4(10):e699-e709. PubMed ID: 38265968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature.
    van Leeuwen NM; Ciaffi J; Schoones JW; Huizinga TWJ; de Vries-Bouwstra JK
    Arthritis Care Res (Hoboken); 2021 May; 73(5):722-731. PubMed ID: 31962005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.